Medical Innovation Never Stops Act of 2019
This bill requires the Food and Drug Administration (FDA)to accept and review new medical device applications and associated user fees during a lapse in appropriations.Under current law, the FDA is prohibited from accepting new user fees and reviewing medical device submissions during an appropriations lapse.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.